Bellevue Group’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-51,936	Closed	-$3.03M	–	182
2022 Q2	$3.03M	Buy	51,936 +30,800	+146%	+$1.8M	0.04%	119
2022 Q1	$1.61M	Buy	+21,136	New	+$1.61M	0.02%	139